title: Evaluation of chromosomal aberrations in lymphocytes and micronuclei in lymphocytes, oral mucosa and hair root cells of patients under antiblastic therapy.
abstract: In 7 patients undergoing antiblastic chemotherapy for the first time, the structural chromosomal aberration (CA) test in peripheral lymphocytes was compared with the micronucleus (Mn) test in lymphocytes, in oral cavity cells and in hair root cells of the scalp. The last test is being proposed for the first time. The CA and Mn frequencies induced by chemotherapy were compared with the baseline (pretreatment) frequencies of the patients and with confidence limits calculated in 4 control groups studied for CA, Mn in lymphocytes, Mn in oral cavity cells and Mn in hair root cells, respectively. The studied chemotherapies induced a clear cytogenetic effect in at least 2 of the tests studied with the exception of interferon-alpha 2b (patient 6) and interferon + low doses of cis-platinum (patient 2) which did not appear to cause evident chromosomal damage. The response to chemotherapy is generally characterized by an increase in Ca and Mn, reaching a peak value and then decreasing in the following weeks. The CA test proves to be the most sensitive despite the fact that CA were analyzed in an average of 100 cells per sample against the 500-3000 cells analyzed for Mn. The efficiency of Mn to detect CA is in the following order: Mn in lymphocytes greater than Mn in buccal cells greater than Mn in hair root cells. The last test appears to be very promising but, used following the current method, does not appear suitable to monitor acute exposure.
authors.affiliation: Instituto di Medicina del Lavoro, Complesso Convenzionato Ospedale Universitá, Padua, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Sarto
authors.forename: R
authors.initials: R
authors.lastname: Tomanin
authors.forename: L
authors.initials: L
authors.lastname: Giacomelli
authors.forename: A
authors.initials: A
authors.lastname: Canova
authors.forename: F
authors.initials: F
authors.lastname: Raimondi
authors.forename: C
authors.initials: C
authors.lastname: Ghiotto
authors.forename: M V
authors.initials: MV
authors.lastname: Fiorentino
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016009:Chi-Square Distribution; D002869:Chromosome Aberrations; D016001:Confidence Intervals; D005069:Evaluation Studies as Topic; D005260:Female; D006198:Hair Cells, Auditory / Q000187:drug effects / Q000648:ultrastructure; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000648:ultrastructure; D008297:Male; D015162:Micronucleus Tests; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects / Q000648:ultrastructure; D009152:Mutagenicity Tests / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents